| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | S1 | 5.39e-05 | 10 | 146 | 3 | PS50126 | |
| Domain | DDI1_N | 6.07e-05 | 2 | 146 | 2 | IPR033882 | |
| Domain | S1 | 9.78e-05 | 12 | 146 | 3 | SM00316 | |
| Domain | S1_dom | 9.78e-05 | 12 | 146 | 3 | IPR022967 | |
| Domain | S1_domain | 9.78e-05 | 12 | 146 | 3 | IPR003029 | |
| Domain | HDAC4_Gln | 1.81e-04 | 3 | 146 | 2 | PF12203 | |
| Domain | Hist_deacetylase_Gln_rich_N | 1.81e-04 | 3 | 146 | 2 | IPR024643 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A LRWD1 RASA3 ZZEF1 PKMYT1 LPIN3 MST1R JUND VAC14 FASN KMT2D MAP1S ZNF827 AHNAK ZNF335 TIGD3 CEP131 BCAM ZNF579 IQGAP3 RAI1 BAHCC1 SYMPK | 4.45e-10 | 1105 | 150 | 23 | 35748872 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ANKFY1 ABCA13 FBF1 TOGARAM1 CRTC1 SRSF11 EPS8L1 GHR VAC14 DDX46 SHROOM1 MAP1S LMNB1 MYO18B | 6.57e-10 | 361 | 150 | 14 | 26167880 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | KIFBP GHDC WFS1 DNAJC16 ELP1 QRICH1 CLSTN1 STX12 FANCD2 VAC14 FASN LMNB1 XPO5 TMEM143 CORO7 VPS51 IQGAP3 ZMYM3 SYMPK | 2.75e-08 | 942 | 150 | 19 | 31073040 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MXRA5 TOPAZ1 VPS13C LAMA1 LARP1 DDI2 NBEA SPAG9 ZZEF1 FAM186B USP20 LMNB1 DQX1 AHNAK RAI1 SYMPK | 1.36e-07 | 736 | 150 | 16 | 29676528 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | KIFBP LRWD1 ILF3 DCTN2 ELP1 SRSF11 DHX8 FANCD2 FASN DDX46 XPO5 AHNAK VPS51 SYMPK | 2.58e-07 | 582 | 150 | 14 | 20467437 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | GPHN KNTC1 LRWD1 ILF3 DCTN2 LARP1 SPAG9 SPECC1 PKMYT1 FASN DDX46 MAP1S LMNB1 AHNAK CEP131 IQGAP3 ZMYM3 ANAPC4 STK25 | 6.29e-07 | 1155 | 150 | 19 | 20360068 |
| Pubmed | ELP1 LARP1 SPAG9 DHX8 FASN DDX46 XPO5 SUPT6H AHNAK ZNF512 ZMYM3 CAP1 RAI1 SYMPK | 1.01e-06 | 653 | 150 | 14 | 22586326 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GPHN PRUNE2 KNTC1 KIFBP ANKFY1 DCTN2 ELP1 LARP1 APEX1 DDI2 SPAG9 QRICH1 ZZEF1 RPP25 FANCD2 FASN MAP1S LMNB1 XPO5 AHNAK CAP1 | 1.27e-06 | 1455 | 150 | 21 | 22863883 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | LRWD1 ILF3 LARP1 SPAG9 FANCD2 JUND FASN KMT2D DDX46 MAP1S ZNF335 TRAPPC10 ZNF579 ZMYM3 SYMPK | 1.43e-06 | 774 | 150 | 15 | 15302935 |
| Pubmed | KNTC1 FKBP15 KIFBP LRCH2 HDAC4 FBF1 ELP1 LARP1 MAP1S TRAPPC10 CEP131 | 4.11e-06 | 446 | 150 | 11 | 24255178 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCOA2 GPHN KIFBP LRWD1 PLEKHG4 LARP1 SPAG9 QRICH1 JUND FASN KMT2D LRP1 ZBTB10 ZMYM3 SYMPK | 4.94e-06 | 857 | 150 | 15 | 25609649 |
| Pubmed | NCOA2 GPHN SETD1A DCTN2 LARP1 SPAG9 FASN KMT2D DDX46 LMNB1 AHNAK SYMPK | 5.10e-06 | 549 | 150 | 12 | 38280479 | |
| Pubmed | NCOA2 KNTC1 LRWD1 ILF3 HDAC4 MBNL1 GATA1 LARP1 APEX1 QRICH1 JUND FASN KMT2D XPO5 ZMYM3 CAP1 RAI1 | 6.06e-06 | 1103 | 150 | 17 | 34189442 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GPHN FKBP15 KIFBP LRCH2 HDAC4 DCTN2 MBNL1 LARP1 CRTC1 IFT46 SPAG9 LPIN3 XPO5 AHNAK TRAPPC10 CEP131 VPS51 IQGAP3 | 1.68e-05 | 1321 | 150 | 18 | 27173435 |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 19224914 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 31127039 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 26366710 | ||
| Pubmed | Deubiquitinases USP20/33 promote the biogenesis of tail-anchored membrane proteins. | 1.85e-05 | 2 | 150 | 2 | 33792613 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 32366932 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 14570900 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24956203 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 29937342 | ||
| Pubmed | SETD1A KIFBP BRPF3 VPS13C FBF1 LARP1 CRTC1 ZZEF1 DDX46 SUPT6H RAI1 | 2.02e-05 | 529 | 150 | 11 | 14621295 | |
| Pubmed | ANKFY1 ILF3 DNAJC16 ELP1 SPAG9 FASN DDX46 LMNB1 XPO5 SUPT6H CAP1 SYMPK | 2.27e-05 | 638 | 150 | 12 | 33239621 | |
| Pubmed | 2.66e-05 | 199 | 150 | 7 | 23382691 | ||
| Pubmed | 2.76e-05 | 14 | 150 | 3 | 15964851 | ||
| Pubmed | 3.60e-05 | 43 | 150 | 4 | 33472061 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 KIFBP ANKFY1 ILF3 VPS13C ELP1 LARP1 STX12 DHX8 FANCD2 FASN LMNB1 XPO5 SUPT6H MYO18B ZNF512 IQGAP3 CAP1 | 4.53e-05 | 1425 | 150 | 18 | 30948266 |
| Pubmed | GPHN ILF3 LRCH2 WFS1 DCTN2 ELP1 LARP1 NBEA BCAN SPECC1 FASN MAP1S SLC27A1 SCN2A TRAPPC10 CORO7 VPS51 CAP1 | 4.78e-05 | 1431 | 150 | 18 | 37142655 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 19284629 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 29788202 | ||
| Pubmed | Blocking the association of HDAC4 with MAP1S accelerates autophagy clearance of mutant Huntingtin. | 5.53e-05 | 3 | 150 | 2 | 26540094 | |
| Pubmed | An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis. | 5.53e-05 | 3 | 150 | 2 | 28729415 | |
| Pubmed | HDAC4 deacetylase associates with and represses the MEF2 transcription factor. | 5.53e-05 | 3 | 150 | 2 | 10487761 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 12056827 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 19454653 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 31754707 | ||
| Pubmed | UBX Domain Protein 6 Positively Regulates JAK-STAT1/2 Signaling. | 5.53e-05 | 3 | 150 | 2 | 34021047 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 28419090 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 27333946 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 22843687 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 12865408 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 35930768 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 23297420 | ||
| Pubmed | Nucleocytoplasmic shuttling of JAZ, a new cargo protein for exportin-5. | 5.53e-05 | 3 | 150 | 2 | 15254228 | |
| Pubmed | PRUNE2 HDAC9 KNTC1 TTC14 TOGARAM1 SPAG9 CLSTN1 USP20 ZNF512 TMEM63A | 5.97e-05 | 493 | 150 | 10 | 15368895 | |
| Pubmed | 6.56e-05 | 50 | 150 | 4 | 26275350 | ||
| Pubmed | GPHN FKBP15 WFS1 DNAJC16 VPS13C NBEA STX12 PKMYT1 VAC14 USP33 | 7.17e-05 | 504 | 150 | 10 | 34432599 | |
| Pubmed | 7.24e-05 | 19 | 150 | 3 | 18445686 | ||
| Pubmed | 7.43e-05 | 234 | 150 | 7 | 36243803 | ||
| Pubmed | NCOA2 GPHN FKBP15 KIFBP ANKFY1 ILF3 LRCH2 HDAC4 NBEA ZNF394 LMNB1 LRP1 CEP131 RAI1 | 7.80e-05 | 963 | 150 | 14 | 28671696 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 PRUNE2 CDH26 HDAC4 CRADD RASA3 VPS13C MBNL1 TTC14 LARP1 SRSF11 ZNF827 SUPT6H LRP1 TMEM143 ZNF512 RAI1 TMEM63A | 7.93e-05 | 1489 | 150 | 18 | 28611215 |
| Pubmed | Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules. | 8.49e-05 | 20 | 150 | 3 | 21421818 | |
| Pubmed | 8.97e-05 | 418 | 150 | 9 | 34709266 | ||
| Pubmed | 9.88e-05 | 330 | 150 | 8 | 21044950 | ||
| Pubmed | NCOA2 MXRA5 ANKFY1 FBF1 ELP1 NBEA RYR2 KMT2D HERC6 ZNF512 RAI1 | 1.08e-04 | 638 | 150 | 11 | 31182584 | |
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 21525354 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 10594042 | ||
| Pubmed | HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. | 1.10e-04 | 4 | 150 | 2 | 10523670 | |
| Pubmed | Deacetylation of Glutaminase by HDAC4 contributes to Lung Cancer Tumorigenesis. | 1.10e-04 | 4 | 150 | 2 | 35864951 | |
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 12860387 | ||
| Pubmed | mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. | 1.10e-04 | 4 | 150 | 2 | 10748098 | |
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 19424180 | ||
| Pubmed | Class IIa histone deacetylases: conducting development and differentiation. | 1.10e-04 | 4 | 150 | 2 | 19412888 | |
| Pubmed | Mfge8 promotes obesity by mediating the uptake of dietary fats and serum fatty acids. | 1.10e-04 | 4 | 150 | 2 | 24441829 | |
| Pubmed | 1.15e-04 | 251 | 150 | 7 | 31076518 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.41e-04 | 444 | 150 | 9 | 34795231 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 1.57e-04 | 264 | 150 | 7 | 32814769 | |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 1.72e-04 | 119 | 150 | 5 | 35776542 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.75e-04 | 457 | 150 | 9 | 32344865 | |
| Pubmed | 1.79e-04 | 360 | 150 | 8 | 33111431 | ||
| Pubmed | 1.83e-04 | 5 | 150 | 2 | 8812438 | ||
| Pubmed | 1.83e-04 | 5 | 150 | 2 | 15194749 | ||
| Pubmed | Exportin-5, a novel karyopherin, mediates nuclear export of double-stranded RNA binding proteins. | 1.83e-04 | 5 | 150 | 2 | 11777942 | |
| Pubmed | 1.83e-04 | 5 | 150 | 2 | 18332106 | ||
| Pubmed | Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation. | 1.83e-04 | 5 | 150 | 2 | 14668799 | |
| Pubmed | The proline-rich tyrosine kinase Pyk2 regulates platelet integrin αIIbβ3 outside-in signaling. | 1.83e-04 | 5 | 150 | 2 | 23216754 | |
| Pubmed | 1.83e-04 | 5 | 150 | 2 | 19893013 | ||
| Pubmed | 1.83e-04 | 5 | 150 | 2 | 19940148 | ||
| Pubmed | 1.83e-04 | 5 | 150 | 2 | 26744420 | ||
| Pubmed | A molecular mechanism to regulate lysosome motility for lysosome positioning and tubulation. | 1.83e-04 | 5 | 150 | 2 | 26950892 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | NCOA2 SETD1A CALCB DCTN2 LARP1 SPAG9 IRX3 FASN LMNB1 CEP131 HS3ST3A1 IQGAP3 SYMPK | 1.91e-04 | 922 | 150 | 13 | 27609421 |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 2.16e-04 | 125 | 150 | 5 | 21654808 | |
| Pubmed | 2.24e-04 | 126 | 150 | 5 | 17897319 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | GHDC WFS1 STX12 PKMYT1 FASN LMNB1 XPO5 AHNAK SLC27A1 LRP1 BCAM ZNF512 ZMYM3 ANAPC4 SYMPK | 2.32e-04 | 1203 | 150 | 15 | 29180619 |
| Pubmed | 2.50e-04 | 285 | 150 | 7 | 34369648 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.55e-04 | 202 | 150 | 6 | 33005030 | |
| Pubmed | NCOA2 KLF12 ANKFY1 MBNL1 GATA1 QRICH1 IRX3 PHF1 JUND PROX2 ZMYM3 | 2.69e-04 | 709 | 150 | 11 | 22988430 | |
| Pubmed | 2.72e-04 | 72 | 150 | 4 | 36376293 | ||
| Pubmed | Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. | 2.74e-04 | 6 | 150 | 2 | 10825153 | |
| Pubmed | 2.74e-04 | 6 | 150 | 2 | 19522008 | ||
| Pubmed | Ethanol increases fetal human neurosphere size and alters adhesion molecule gene expression. | 2.74e-04 | 6 | 150 | 2 | 18162078 | |
| Pubmed | Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis. | 2.74e-04 | 6 | 150 | 2 | 26366712 | |
| Pubmed | 2.74e-04 | 6 | 150 | 2 | 34933446 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 2.74e-04 | 6 | 150 | 2 | 23652591 | |
| Pubmed | Ccdc13 is a novel human centriolar satellite protein required for ciliogenesis and genome stability. | 2.74e-04 | 6 | 150 | 2 | 24816561 | |
| Pubmed | Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. | 2.74e-04 | 6 | 150 | 2 | 16356933 | |
| Pubmed | USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110. | 2.74e-04 | 6 | 150 | 2 | 23486064 | |
| Pubmed | CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. | 2.74e-04 | 6 | 150 | 2 | 9804823 | |
| Pubmed | 2.87e-04 | 73 | 150 | 4 | 22094256 | ||
| Cytoband | 12q13.3 | 2.43e-05 | 51 | 150 | 4 | 12q13.3 | |
| GeneFamily | Histone deacetylases, class IIA | 1.70e-04 | 4 | 97 | 2 | 992 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.00e-03 | 9 | 97 | 2 | 1203 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100 | 1.24e-05 | 21 | 148 | 4 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k2_100 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.34e-07 | 186 | 150 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-06 | 166 | 150 | 7 | f4698fd08965936d51695d571bd10fb77330d916 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-06 | 173 | 150 | 7 | 23e50492bc673aff9df95d97f0b9be4ce57cbf01 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.31e-06 | 200 | 150 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 5.31e-06 | 200 | 150 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 5.31e-06 | 200 | 150 | 7 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.44e-05 | 155 | 150 | 6 | a4f2fffa8d0de760c556c3f8f1c91804eedbfa68 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 160 | 150 | 6 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 160 | 150 | 6 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-05 | 161 | 150 | 6 | 8ec923c230a7a3cce5edf2a736b3a00d607c698a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 165 | 150 | 6 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 166 | 150 | 6 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 166 | 150 | 6 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-05 | 167 | 150 | 6 | 7efa0081e79f22b219eac64ffcaedb2179cde299 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-05 | 169 | 150 | 6 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 174 | 150 | 6 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-05 | 179 | 150 | 6 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-05 | 180 | 150 | 6 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-05 | 180 | 150 | 6 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 186 | 150 | 6 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-05 | 186 | 150 | 6 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.27e-05 | 188 | 150 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.27e-05 | 188 | 150 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 189 | 150 | 6 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 4.40e-05 | 189 | 150 | 6 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.66e-05 | 191 | 150 | 6 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-05 | 191 | 150 | 6 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.80e-05 | 192 | 150 | 6 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.08e-05 | 194 | 150 | 6 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.08e-05 | 194 | 150 | 6 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 5.23e-05 | 195 | 150 | 6 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-05 | 195 | 150 | 6 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | (0)_NK_cells-(0)_NK_CD160pos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.23e-05 | 195 | 150 | 6 | 6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-05 | 197 | 150 | 6 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.69e-05 | 198 | 150 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-05 | 198 | 150 | 6 | c506334d81af672ef9ddc8c4fd2a790bdb58e63e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.69e-05 | 198 | 150 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-A_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.85e-05 | 199 | 150 | 6 | 09cf004032e5af912ee0cdde6e24ce3bcf7673cd | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.85e-05 | 199 | 150 | 6 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | BAL-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 5.85e-05 | 199 | 150 | 6 | da180aaa53f995183522da0f2321bf0c0c8ee6ec | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-05 | 200 | 150 | 6 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 6.02e-05 | 200 | 150 | 6 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A | CRADD RIBC2 FPGS BCAN EPS8L1 RYR2 JUND MAP1S BCAM HERC6 ZMYM3 | 8.47e-08 | 198 | 150 | 11 | 5533_DN |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; PC3; HT_HG-U133A | 5.80e-06 | 194 | 150 | 9 | 4248_DN | |
| Drug | Vinpocetine [42971-09-5]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 6.57e-06 | 197 | 150 | 9 | 3174_UP | |
| Drug | Vitamin K2 [11032-49-8]; Up 200; 9uM; PC3; HT_HG-U133A | 6.57e-06 | 197 | 150 | 9 | 3798_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; HL60; HG-U133A | 6.84e-06 | 198 | 150 | 9 | 2005_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 3.74e-05 | 189 | 150 | 8 | 3733_DN | |
| Drug | geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A | 3.89e-05 | 190 | 150 | 8 | 4452_DN | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A | 4.19e-05 | 192 | 150 | 8 | 4330_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 4.51e-05 | 194 | 150 | 8 | 4331_DN | |
| Drug | PF-00539745-00 [351321-33-0]; Down 200; 10uM; PC3; HT_HG-U133A | 4.67e-05 | 195 | 150 | 8 | 5979_DN | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | 4.67e-05 | 195 | 150 | 8 | 2104_UP | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 4591_UP | |
| Drug | Methotrexate [59-05-2]; Up 200; 8.8uM; PC3; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 6318_UP | |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; PC3; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 5045_UP | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 1641_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 6031_DN | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 5392_DN | |
| Drug | Tridihexethyl chloride; Up 200; 11.4uM; PC3; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 5067_UP | |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 6089_DN | |
| Drug | Nitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 5405_DN | |
| Drug | Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 5886_UP | |
| Drug | Ungerine nitrate; Up 200; 10.2uM; MCF7; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 6076_UP | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.59e-05 | 200 | 150 | 8 | 6029_UP | |
| Drug | Propantheline bromide [50-34-0]; Up 200; 9uM; MCF7; HT_HG-U133A | 5.59e-05 | 200 | 150 | 8 | 3352_UP | |
| Drug | CP-60 | 7.20e-05 | 34 | 150 | 4 | CID000452626 | |
| Disease | myelodysplastic syndrome (is_marker_for) | 1.22e-04 | 20 | 144 | 3 | DOID:0050908 (is_marker_for) | |
| Disease | hair colour measurement | HDAC9 ILF3 HDAC4 RASA3 MBNL1 ITGB3 KMT2D ZFP36L1 AHNAK LRP1 CSGALNACT1 | 2.27e-04 | 615 | 144 | 11 | EFO_0007822 |
| Disease | Intellectual Disability | 3.64e-04 | 447 | 144 | 9 | C3714756 | |
| Disease | pulse pressure measurement | HDAC9 BRPF3 MXRA5 CRADD MBNL1 DDI2 NBEA ARHGEF25 FAM186B DHX8 VAC14 FASN ZNF827 SUPT6H LRP1 CORO7 STK25 | 4.63e-04 | 1392 | 144 | 17 | EFO_0005763 |
| Disease | forced expiratory volume | HDAC9 SETD1A ILF3 HDAC4 CRADD LARP1 DENND2D RYR2 AHNAK VRTN CSGALNACT1 ANAPC4 | 5.10e-04 | 789 | 144 | 12 | EFO_0004314 |
| Disease | Profound Mental Retardation | 6.15e-04 | 139 | 144 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 6.15e-04 | 139 | 144 | 5 | C0025363 | |
| Disease | Mental deficiency | 6.15e-04 | 139 | 144 | 5 | C0917816 | |
| Disease | Autism Spectrum Disorders | 8.11e-04 | 85 | 144 | 4 | C1510586 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 8.33e-04 | 9 | 144 | 2 | C3502809 | |
| Disease | diffuse scleroderma | 8.33e-04 | 9 | 144 | 2 | EFO_0000404 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | serum IgG glycosylation measurement | 1.11e-03 | 523 | 144 | 9 | EFO_0005193 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 1.13e-03 | 93 | 144 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | eye measurement, sun exposure measurement | 1.26e-03 | 11 | 144 | 2 | EFO_0004731, EFO_0010729 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.26e-03 | 11 | 144 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Schizophrenia | HDAC9 SETD1A KLF12 HDAC4 ABCA13 MBNL1 LAMA1 ITGB3 RGS12 LRP1 MDGA1 RAI1 | 1.35e-03 | 883 | 144 | 12 | C0036341 |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.51e-03 | 12 | 144 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | response to antidepressant | 1.76e-03 | 176 | 144 | 5 | GO_0036276 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.78e-03 | 13 | 144 | 2 | C0751122 | |
| Disease | cardiotoxicity, response to anthracycline-based chemotherapy | 2.07e-03 | 14 | 144 | 2 | EFO_0005257, EFO_1001482 | |
| Disease | Anilide use measurement | 2.38e-03 | 15 | 144 | 2 | EFO_0009938 | |
| Disease | cutaneous melanoma, hair color | 3.49e-03 | 62 | 144 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 3.65e-03 | 63 | 144 | 3 | EFO_0022335 | |
| Disease | cortical surface area change measurement, age at assessment | 3.83e-03 | 19 | 144 | 2 | EFO_0008007, EFO_0021503 | |
| Disease | Cannabis use, age at onset | 3.83e-03 | 19 | 144 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | diaphragmatic hernia | 4.67e-03 | 21 | 144 | 2 | EFO_0008561 | |
| Disease | susceptibility to mononucleosis measurement | 4.71e-03 | 69 | 144 | 3 | EFO_0008403 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDKLAAGLDERLFPP | 666 | Q8N350 | |
| ELSDNPGLLGEDSLK | 1136 | Q5RHP9 | |
| RDGLPVLIPKEDSLL | 1911 | Q9P281 | |
| RALLPLDKQALGDIP | 536 | Q86VW2 | |
| AEDESNLLLPKLPTL | 131 | Q9UJX5 | |
| PDPATLSKEDARLLL | 36 | P10092 | |
| LGLDRSPPEKTQADL | 106 | Q8TDX6 | |
| PLLADDNKLRGLPLT | 321 | P22760 | |
| IFLRDEEPLLKSPGA | 146 | Q13588 | |
| PAENKLSDLLAPISE | 96 | Q01518 | |
| DLPDLPLSDILKGRT | 886 | Q5M775 | |
| LVGKPDILLLDEPSS | 4871 | Q86UQ4 | |
| ELLEKSPLQLGNEPL | 881 | Q9ULD4 | |
| PKLEGELQAPDLELS | 5111 | Q09666 | |
| NTVLLDPPLIALDKD | 51 | O94985 | |
| GSKDTESLEPVLLPL | 406 | Q8IYM0 | |
| ENKLPAELQELPGLS | 101 | P27695 | |
| KLLGPDAAINLTDPD | 156 | Q13561 | |
| TPGFLKLLLDAPAED | 201 | Q96Q80 | |
| GDLPLLPPTSRKEDL | 851 | Q7Z5J4 | |
| SPLRDLLLKSADVEP | 301 | Q14644 | |
| ELLLPNSLKPEEGLE | 466 | Q2TAL8 | |
| TLLKFDTLLPPGRLD | 281 | Q7Z6M1 | |
| LNPEDDLLPGKIRDS | 511 | Q9NQX3 | |
| ELLGEDLPLEPSVTK | 1291 | O60271 | |
| PKLEELSLEGNPFLT | 91 | Q9UFC0 | |
| PLDKPDADGSTVLLL | 1036 | Q9P2R3 | |
| SRVDKEAALLPSGLP | 476 | Q8NFP4 | |
| DVLADLGSLKPSADP | 701 | Q9Y5G9 | |
| LGDPPEKLTLEEARA | 261 | Q96GW7 | |
| DLSLLKERNPPLAEA | 156 | Q8WTU0 | |
| KERNPPLAEALLSGS | 161 | Q8WTU0 | |
| LPKGLSASLPDLDSE | 541 | Q6PKG0 | |
| DLTKNPGLLDDPNLV | 466 | Q9BQK8 | |
| ALLGNELDPLPEKVL | 991 | P56524 | |
| IPAGEEKALELPLAA | 616 | Q66K74 | |
| IRGIPLDPNDKSDAL | 1901 | Q07954 | |
| APILLPDLEGTKLSN | 126 | A8MQB3 | |
| PDLGLLKLASPELER | 91 | P17535 | |
| LEGEEERLKLSPSPS | 381 | P20700 | |
| PLLDPDSGLLVLAGK | 266 | P57737 | |
| ALSEIKDGSLPPELS | 1016 | Q5T1M5 | |
| TPGTKDPRALLLDAL | 176 | Q8N2G8 | |
| KPSLEDLKELSPRLG | 791 | Q8IVU3 | |
| RKDPALLSSEAVLPD | 486 | Q9Y2G8 | |
| PGDLAALPALEELDL | 71 | P0C6S8 | |
| EQGEDCLLLLKSLPP | 906 | P50748 | |
| SLKEGSPLEDLALLE | 1206 | O95163 | |
| APPGTLALLLDEGSK | 136 | Q9Y663 | |
| RLPILLKGTSDDDVP | 16 | Q96N21 | |
| SDGSLVPELLLEKPL | 186 | Q9Y5F7 | |
| ILPVNLSGDLLDKDP | 161 | O94886 | |
| DLSDPLALKKDLPAR | 116 | Q9H4K1 | |
| SEFPLAPELAKALLA | 466 | Q8TE96 | |
| ALLLPAAGLDDVSLP | 546 | Q86VI3 | |
| DLLDLIPSLSPTKNG | 201 | Q6P4A8 | |
| ATPLKLDPLGPLASE | 311 | Q86Y26 | |
| LADLLSPEKQRDPLA | 436 | Q86Y26 | |
| KFLLLGLSDDPELQP | 11 | Q8NG98 | |
| PSGAPASLEILRKEL | 216 | Q3B8N5 | |
| LKTERLSPDLLTLGP | 136 | P15976 | |
| LLPEQSPAGLLQDKD | 96 | Q8NBI3 | |
| LGLKDEDLDLFPASP | 346 | Q8TES7 | |
| LLDAKPDLPTLSRIE | 1196 | B1AJZ9 | |
| PDNLGLLVLDEPSTK | 126 | Q9NQC8 | |
| GLILNATALPLPDKE | 606 | P10912 | |
| GPKSLLSLELKDDRP | 221 | P15391 | |
| PLDELKIDPLTLDGL | 596 | Q6UUV9 | |
| DALPRSGLNLKEEPL | 6 | Q9BQW3 | |
| SGLNLKEEPLLPAGL | 11 | Q9BQW3 | |
| KNADEAELRLLASPP | 316 | Q9P218 | |
| LLLDILPSRGPKAFD | 56 | P78560 | |
| ALAALEKLFPDTPLA | 581 | Q12906 | |
| LGDELLLAKLPPSRE | 276 | Q6UXB0 | |
| SLKRPLEATFDLGIP | 276 | Q9NR56 | |
| LQPDLLDSLGSKATP | 806 | Q8IXH8 | |
| ALPLGSPRCDLKENL | 56 | P05106 | |
| TGDRDPAALLKLLQP | 416 | Q05932 | |
| LLLNNVKGEPPEDSL | 56 | Q9Y4X4 | |
| NPPLAEALLSGDLEK | 156 | Q5TDH0 | |
| PLDGQKLDPRILLGD | 706 | Q9UKV0 | |
| KALELSGTAVPPDLE | 736 | Q7L014 | |
| EGLLTLRAKPPSEAE | 301 | Q8TE68 | |
| RPKLPEDPLLSGLLD | 1206 | P49327 | |
| EDPLLSGLLDSPALK | 1211 | P49327 | |
| LDPLELSEGKVLSLP | 361 | P50895 | |
| RKPLEAALPSEDLTD | 4351 | Q92736 | |
| EPPEDGTLLSEAKLQ | 516 | Q9UPN4 | |
| PSIEPGNLLKDLFET | 626 | Q8NG08 | |
| ALLEEVKALLGPAPE | 41 | Q96EK5 | |
| LIGSEPGPAEELAKL | 11 | Q14562 | |
| LPPKLQDDILDSLGQ | 346 | Q9H6A0 | |
| GPPELLFLLEDLSQK | 961 | Q9BXW9 | |
| PDELGDLPLVKLDFS | 241 | Q5VUJ6 | |
| SSEGLEDRPLPVLSL | 296 | P78415 | |
| DLPSRVEIKPGDELL | 426 | A6NHM9 | |
| DSLLLGELSDTPKGE | 286 | O43189 | |
| AILLSKDALDPRQPG | 136 | Q9BUL9 | |
| PDPNVKSGSELLDRL | 146 | Q08AM6 | |
| PELSLDLEPLLKAGL | 731 | P52630 | |
| DLEPLLKAGLDLGPE | 736 | P52630 | |
| GDPPLEEDSLKQSLA | 2376 | Q8WUY3 | |
| KPLESLALEEASGPV | 2681 | Q8WUY3 | |
| LPPEVGDLKELQTLD | 126 | Q86X40 | |
| SGLPKPADCLLAQDL | 171 | Q58EX7 | |
| LINGRPSADDLSPKL | 201 | P25391 | |
| NGPLITLADEKEDLP | 1126 | Q8NFP9 | |
| KLSDFAAALDPPLLI | 1801 | Q15858 | |
| KDSAAALSDRELPLP | 16 | Q92565 | |
| ESDLLKPVPADALGL | 496 | Q2M3G4 | |
| LSLLALPLAGAAEEP | 6 | Q14940 | |
| LPPREEAELAEGKTL | 771 | O15047 | |
| GSALDLLKPGPLEET | 101 | O00506 | |
| PELNGLDSKLLLDLP | 1251 | Q7RTU9 | |
| DIGLPEITPKLERLD | 756 | Q15596 | |
| TDPLNPLTAEDKELL | 561 | P48736 | |
| DPDKPLADGIRALDT | 431 | Q7KZ85 | |
| EKELRNLEAELGPSP | 281 | Q9UID3 | |
| EPLPTKADALRALGT | 426 | Q6B0B8 | |
| ILSADDLLGSPTLPD | 231 | Q07352 | |
| AGAEPDSILKPELLS | 421 | Q9BZV1 | |
| LPLKLENSPEAEGLN | 251 | Q53GI3 | |
| EKEPLDLGAPISSLD | 1081 | O14924 | |
| DTPLEGLEQLLPELK | 256 | Q96AN5 | |
| LGKIDELRLFPPDDS | 56 | Q05519 | |
| EPDPKLRATAEALLA | 341 | Q99640 | |
| EGILPDTHLLDPLLK | 211 | Q6PCB7 | |
| ETNELLKELGSLPLP | 76 | Q86Y82 | |
| AKLSDFADALDPPLL | 1816 | Q99250 | |
| GNDLGLPPVDLDLDK | 421 | P80108 | |
| LDAEKSAILGLPQPL | 806 | Q9HAV4 | |
| LLEKLGIDESNPPSL | 266 | Q96N46 | |
| PLHLISSSDKPGLDL | 976 | Q709C8 | |
| KLLAELDRSGLPSAP | 46 | Q8IYK8 | |
| TFQDLSLPIPGKEDL | 471 | Q9Y2K6 | |
| AALLDSSLEGPLPKE | 1216 | Q92797 | |
| LATVLKPDEGTADLP | 526 | Q8IUG5 | |
| VPPDSKLGQDLLRDA | 21 | P98182 | |
| SLLAEKSSLLPEDPL | 301 | Q17R98 | |
| DPRGLEAAKEAELPL | 96 | Q8N9V7 | |
| DKDPGGLLLLPEKND | 906 | O43149 | |
| IKEEPDLDGALLSGP | 616 | Q96DT7 | |
| IPRGISLLPDKADLS | 916 | Q9Y4F4 | |
| ELKLLEVSVPPGALD | 341 | P48553 | |
| SPAKTLELLNREPGL | 266 | Q9H8Y1 | |
| KLPRLEISDLPDGVE | 356 | Q9H4Z2 | |
| LKAEQEEEGLPLPLA | 491 | Q8NAF0 | |
| LEDESLLPPLGSKEG | 911 | O14939 | |
| NSLPILKAGDEIDEP | 221 | Q96ME7 | |
| GDTDTKVLVLDPALP | 116 | Q04912 | |
| STPDGLPQLEREEKL | 51 | Q02386 | |
| ALDLLDTPAGLEKDP | 56 | Q14202 | |
| TFQDLSLPIPGKEDL | 501 | Q8TEY7 | |
| PLEGLDLQPFLAKDS | 636 | Q8TEY7 | |
| DDELAGKSPEDLPLR | 271 | O76024 | |
| SELKGSPVLLDPEEL | 1146 | O14686 | |
| GENLTDPPLLKELED | 1401 | Q9NR99 |